| 1 |
35171329 | Meta-analysis of aspirin-guided therapy of colorectal cancer. | 2022 Jun |
2 |
| 2 |
33574709 | siRNA Knockdown of REDD1 Facilitates Aspirin-Mediated Dephosphorylation of mTORC1 Target 4E-BP1 in MDA-MB-468 Human Breast Cancer Cell Line. | 2021 |
1 |
| 3 |
34537546 | Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformations. | 2021 Dec |
3 |
| 4 |
34638442 | Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors. | 2021 Oct 1 |
3 |
| 5 |
31904094 | A comprehensive in vivo and mathematic modeling-based kinetic characterization for aspirin-induced chemoprevention in colorectal cancer. | 2020 Jul 10 |
1 |
| 6 |
32000660 | Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway. | 2020 Jan 30 |
7 |
| 7 |
32326897 | Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer. | 2020 Apr 23 |
5 |
| 8 |
32365457 | Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition. | 2020 Apr 30 |
8 |
| 9 |
32646396 | Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis. | 2020 Jul 9 |
2 |
| 10 |
31262687 | Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis. | 2019 Oct |
3 |
| 11 |
29153543 | [Aspirin and colorectal cancer]. | 2018 Feb |
1 |
| 12 |
29402752 | Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK). | 2018 Mar |
2 |
| 13 |
29850157 | Aspirin acts in esophageal cancer: a brief review. | 2018 Apr |
1 |
| 14 |
27800646 | Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer. | 2017 Jan |
1 |
| 15 |
27940576 | Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling. | 2017 Feb 1 |
5 |
| 16 |
28154202 | Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells. | 2017 Mar |
6 |
| 17 |
28219002 | Molecular Testing for Gastrointestinal Cancer. | 2017 Mar |
1 |
| 18 |
28448072 | Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study. | 2017 Apr 27 |
1 |
| 19 |
28525374 | The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS). | 2017 Jul 11 |
1 |
| 20 |
28849118 | Aspirin inhibits the proliferation of human uterine leiomyoma cells by downregulation of K‑Ras‑p110α interaction. | 2017 Oct |
5 |
| 21 |
29152088 | Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells. | 2017 Oct 20 |
14 |
| 22 |
29552640 | Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. | 2017 |
1 |
| 23 |
26712086 | PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies. | 2016 May |
4 |
| 24 |
26915040 | Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin. | 2016 Feb |
6 |
| 25 |
27096951 | Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. | 2016 |
1 |
| 26 |
27268661 | Mutations in PIK3CA Sensitize Breast Cancer Cells to Physiologic Levels of Aspirin. | 2016 |
1 |
| 27 |
25239119 | Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. | 2015 Sep |
2 |
| 28 |
25388762 | Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737. | 2015 Feb |
2 |
| 29 |
25549537 | Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation. | 2015 Apr |
3 |
| 30 |
23792451 | Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. | 2014 Jun 5 |
3 |
| 31 |
24355100 | DNA testing and molecular screening for colon cancer. | 2014 Mar |
1 |
| 32 |
24624362 | PIK3CA in Colorectal Cancer. | 2014 |
1 |
| 33 |
24840525 | Aspirin in gastrointestinal oncology: new data on an old friend. | 2014 Jul |
1 |
| 34 |
25180765 | Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies. | 2014 Nov 25 |
1 |
| 35 |
23207797 | Potential biomarker for aspirin use in colorectal cancer therapy. | 2013 Jan |
2 |
| 36 |
24062397 | Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. | 2013 Dec 1 |
5 |
| 37 |
24166520 | Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex! | 2013 Dec 1 |
1 |
| 38 |
25332957 | Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy? | 2013 Jul |
1 |
| 39 |
23094721 | Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. | 2012 Oct 25 |
6 |